Using <scp>PBPK</scp> to Simulate Target Biopredictive Dissolution Profiles for Long‐Acting Injectables ‐ Where to Begin With Critical Bioavailability Attributes?

Hannah Cleary, Nikoletta Fotaki, Tim Persoons, Deirdre M. D'Arcy

Open source

DOI
10.1002/psp4.70212
Published
2026-02-18
Container
CPT: Pharmacometrics &amp; Systems Pharmacology
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/psp4.70212,
  title = {Using
                    <scp>PBPK</scp>
                    to Simulate Target Biopredictive Dissolution Profiles for Long‐Acting Injectables ‐ Where to Begin With Critical Bioavailability Attributes?},
  author = {Hannah Cleary and Nikoletta Fotaki and Tim Persoons and Deirdre M. D'Arcy},
  year = {2026},
  journal = {CPT: Pharmacometrics \&amp; Systems Pharmacology},
  doi = {10.1002/psp4.70212},
  url = {https://doi.org/10.1002/psp4.70212}
}

RIS

TY  - JOUR
TI  - Using
                    <scp>PBPK</scp>
                    to Simulate Target Biopredictive Dissolution Profiles for Long‐Acting Injectables ‐ Where to Begin With Critical Bioavailability Attributes?
AU  - Hannah Cleary
AU  - Nikoletta Fotaki
AU  - Tim Persoons
AU  - Deirdre M. D'Arcy
PY  - 2026
JO  - CPT: Pharmacometrics &amp; Systems Pharmacology
DO  - 10.1002/psp4.70212
UR  - https://doi.org/10.1002/psp4.70212
ER  - 

APA

Cleary, H., Fotaki, N., Persoons, T., & D'Arcy, D. M. (2026). Using <scp>PBPK</scp> to Simulate Target Biopredictive Dissolution Profiles for Long‐Acting Injectables ‐ Where to Begin With Critical Bioavailability Attributes?. CPT: Pharmacometrics &amp; Systems Pharmacology. https://doi.org/10.1002/psp4.70212

Source records